vimarsana.com

Page 47 - ஹாங் காங் பாலிடெக்நிக் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HKBU develops dual-targeting drug for EBV-related cancers

Hong Kong Baptist University  A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has thepotential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV). The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have successfully targeted two viral proteins that are simultaneously produced by EBV. It also offers a new strategy by increasing the uptake of anti-cancer drugs in tumour cells, thus allowing the application of lower drug dosages which helps reduce treatment side effects and health risks. The research results were published in the international academic journal

CB Scientific, Inc Announces Appointment of New Director for Asia Pacific | Taiwan News

CBSC has appointed Jeslie Chui as Director of Business Development Asia Pacific Escondido, California - Newsfile Corp. - March 2, 2021 - CB Scientific. Inc. (OTC Pink: CBSC) ( CBSC or the Company ), in an ongoing effort to expand its outreach in the Ambulatory Remote Cardiac Diagnostic Monitoring products and services market globally, is pleased to announce the appointment of Jeslie Chui as Director of Business Development Asia Pacific for CB Scientific Inc. effective March 1, 2021. In this position Mr. Chui will work to increase company recognition and awareness of CBSC and its subsidiary My-Cardia, identify and develop corporate strategies for expansion and the associated marketing platforms to support these strategies, and assist in corporate fundraising in the region. Through his various entrepreneurial roles in Hong Kong and China, Jeslie Chui has been instrumental in raising venture capital including financial advisory and business development for companies from

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.